NF1 and neoplasm: These NF1-dependent phenotypes are further exacerbated when NF1 is concomitantly deleted with other tumor suppressors (e.g.; p53 and p19ARF) resulting in more aggressive phenotypes as evidenced by malignant peripheral nerve sheath tumor formation [63,64].